Source:http://linkedlifedata.com/resource/pubmed/id/19891698
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2010-7-20
|
pubmed:abstractText |
Life-long testosterone replacement therapy (TRT) for younger men with organic androgen deficiency is best provided by depot testosterone (T) products. This study compared directly the two long-acting depot T products, subdermal T implants (TI) and injectable T undecanoate (TU) for maintenance of TRT.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1365-2265
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
102-9
|
pubmed:meshHeading |
pubmed-meshheading:19891698-Androgens,
pubmed-meshheading:19891698-Cross-Over Studies,
pubmed-meshheading:19891698-Drug Implants,
pubmed-meshheading:19891698-Hormone Replacement Therapy,
pubmed-meshheading:19891698-Humans,
pubmed-meshheading:19891698-Hypogonadism,
pubmed-meshheading:19891698-Male,
pubmed-meshheading:19891698-Patient Satisfaction,
pubmed-meshheading:19891698-Quality of Life,
pubmed-meshheading:19891698-Testosterone
|
pubmed:year |
2010
|
pubmed:articleTitle |
Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men.
|
pubmed:affiliation |
Andrology Department, Concord Hospital & ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|